Sun, Y., Jiang, F., Gu, J.J., Wang, Y.K., Hua, H., Li, J., . . . Ding, G. (2017). Development and testing of an intelligent pain management system (IPMS) on mobile phones through a randomized trial among Chinese cancer patients: A new approach in cancer pain management. JMIR mHealth and uHealth, 5, e108.

To test the intelligent pain management system (IPMS) on mobile phones among patients with cancer with pain.

Data regarding pain assessments, satisfaction, and effectiveness of pain management, and change in QOL was recorded through a mobile phone app, the IPMS.

• N = 46   
• MEAN AGE: Trial group, 76 years; control group, 68 years
• MALES: 70%  
• FEMALES: 30%
• CURRENT TREATMENT: Chemotherapy, other: Not specified which type of treatment. Not radiation-exclusion criteria.

• SITE: Single site   
• SETTING TYPE: Outpatient    
• LOCATION: Oncology Center of Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Chongming Branch, China

PHASE OF CARE: Active anti-tumor treatment

Randomized controlled trial

• Karnofsky Performance Status (KPS)
• Pain Management Knowledge
• Paon Assessment

Over the 14-day trial period, the trial group had on a score of on average 0.28 less than the control group (p < 0.001) and at the end of the trial period, 0.75 less than the control group (p < 0.001).

IPMS use as a way to assess pain in patients with cancer has shown promising results. A larger study with a variety of patients with cancer is needed to assess for generalizability.

• Small sample (< 100)
• Baseline sample/group differences of import
• Key sample group differences that could influence results
• Other limitations/explanation: Short duration of the trial period

Using technology such as mobile device apps can be a novel way to maintain constant contact and management of patient pain. It is worthwhile to invest resources in expanding research in this area.